Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01225796 · ClinicalTrials.gov registry record · Early Phase 1
Study of Sodium Bicarbonate in Kidney Transplant Recipients
A Early Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 29
- Enrollment target
NCT01225796: Completed Early Phase 1 study, sponsored by University of Utah.
NCT01225796 is a Early Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 29 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01225796, a Early Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effect of sodium bicarbonate versus no sodium bicarbonate treatment on urinary ammonia levels and urinary transforming growth factor-beta1 (TGF-beta1) excretion in renal transplant patients with low-to-normal serum bicarbonate levels (20 - 28 mmol/L).
Primary Outcome
This is considered a surrogate marker of chronic allograft nephropathy (tubulointerstitial fibrosis).
Interventions
- DRUG Sodium bicarbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-11 |
| Phase | Early Phase 1 |
What the finished NCT01225796 record still lists
NCT01225796 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (45% lower).
The record links to 0 conditions, and to 1 intervention - of which Sodium bicarbonate is the first listed.
NCT01225796 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01225796 about?
NCT01225796 is a clinical study titled "Study of Sodium Bicarbonate in Kidney Transplant Recipients". The purpose of this study is to compare the effect of sodium bicarbonate versus no sodium bicarbonate treatment on urinary ammonia levels and urinary transforming growth factor-beta1 (TGF-beta1) excretion in renal transplant patients with low-to-normal serum bicarbonate levels (20 - 28 mmol/L).
What is the current status of trial NCT01225796?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 29 participants. The study started on 2010-11. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01225796?
The interventions under investigation include: Sodium bicarbonate (DRUG).
Who is sponsoring clinical trial NCT01225796?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01225796's enrollment target sits among peer trials
29 927th of 2000 higher than 1,064 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia